Premise:
We study how the immune system and metabolism interact to regulate glucose levels and drive diseases like diabetes. When cells can’t properly take in or release glucose, it disrupts energy balance and leads to serious health conditions. In Type 1 diabetes, the immune system attacks insulin-producing beta cells. In Type 2 diabetes, often linked to obesity, cells become resistant to insulin. Despite decades of research and growing treatment options, there’s still no cure, and the key molecular pathways remain poorly understood. Our lab is working to uncover the immunometabolic mechanisms behind diabetes and metabolic dysfunction, with the goal of identifying new therapeutic targets. We are always looking for motivated undergraduate and graduate students who are excited to explore the biology of disease, contribute to impactful research, and grow as independent scientists in a supportive and collaborative environment.
Undergraduate Students’ Project:
Title: Identifying Candidate Genes Involved in Impaired Immunometabolic Responses
This project offers undergraduate students immersive, hands-on training in genetic, proteomic, and cellular techniques while reinforcing concepts from their coursework. Our goal is to prepare students with the skills and experience needed for successful admission into competitive PhD programs and biomedical careers. Students will analyze single-cell RNA sequencing (scRNA-seq) datasets from mouse models of type 1 diabetes (non-obese, autoimmune-driven) and type 2 diabetes (diet-induced, obesity-driven) to identify genes that are differentially expressed and potentially involved in chronic inflammation, metabolic dysfunction, or disease progression. Selected candidate genes will then be studied using a range of molecular and cellular techniques including qPCR, western blotting, cell culture, RNA interference (RNAi), ELISA, flow cytometry, and fluorescence/brightfield microscopy.
Project outcomes may include poster presentations at internal and national scientific conferences, co-authorship on manuscripts, and the foundation for long-term projects within the lab.
Graduate Students’ Project:
Title: Delineating Immune-Stromal Interactions in Diet-Induced Obesity and Diabetes
Obesity has risen steadily over the past decade and is now recognized as a major public health challenge. It can manifest as either metabolically healthy or unhealthy obesity, the latter characterized by adipocyte hypertrophy, impaired adipocyte proliferation, immune cell infiltration (particularly macrophages), heightened inflammation, and fibrotic collagen deposition. These features drive adipose tissue dysfunction, ectopic lipid accumulation, and increased risk for type 2 diabetes (T2D), cardiovascular disease, fatty liver disease, and certain cancers. Although immune-adipose interactions, particularly involving myeloid cells and inflammatory signaling have been described, the molecular mechanisms driving these immunometabolic changes remain poorly understood. These projects are ideal for incoming graduate students interested in unraveling the signaling pathways underlying obesity-driven metabolic dysfunction and diabetes. Students will investigate genes of interest using conditional knockout (cKO) models created via lentiviral gene silencing or transgenic breeding strategies.
Experimental approaches will include:
-
In vivo metabolic assessments: body weight monitoring, glucose and insulin tolerance tests, energy expenditure analysis, and body composition using DEXA.
-
Tissue-level studies: adipose and immune cell isolation and culture to assess cell-specific functions and inflammatory profiles.
- Immune cell characterization: Isolation and functional analysis of T cells, regulatory T cells, and antigen-presenting cells to investigate immune activation, tolerance, and autoimmune responses.
-
Molecular and cellular readouts: Luminex multiplex cytokine assays, flow cytometry, qPCR, western blotting, and fluorescence microscopy.
Projects under this umbrella offer opportunities for high-impact research, potential publications, and skill development in both basic and translational immunometabolism.
Title: Engineering Immune Tolerance and Investigating Autoimmune Mechanisms in Type 1 Diabetes
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the progressive destruction of insulin-producing pancreatic β cells by autoreactive immune cells, resulting in lifelong insulin dependence. Despite advances in insulin therapy and glucose management, strategies to prevent or reverse autoimmune β-cell destruction remain limited. The development of T1D involves complex interactions between immune cells, pancreatic islets, and inflammatory signaling pathways that disrupt immune tolerance and promote disease progression. Understanding these mechanisms is essential for developing targeted therapies that preserve β-cell function and restore immune homeostasis.
Our research focuses on understanding the cellular and molecular mechanisms underlying autoimmune diabetes and developing innovative immunotherapeutic approaches to protect pancreatic β cells. Projects will investigate immune cell dysfunction, antigen presentation, and the generation of neoantigens that contribute to autoimmune recognition. Additionally, we aim to explore bioengineering strategies to promote immune tolerance, including engineered regulatory T cells (Tregs) and genetically modified pancreatic islets designed to evade autoimmune destruction.
These projects are ideal for incoming graduate students interested in immunology, autoimmune disease, cellular engineering, and translational diabetes research.
Experimental approaches will include:
- In vivo autoimmune diabetes models: Monitoring diabetes development, blood glucose levels, glucose tolerance, and immune infiltration using mouse models of T1D.
- Immune cell characterization: Isolation and functional analysis of T cells, regulatory T cells, and antigen-presenting cells to investigate immune activation, tolerance, and autoimmune responses.
- Pancreatic islet biology: Isolation and culture of pancreatic islets to assess β-cell viability, inflammatory responses, and interactions with immune cells.
- Cellular and genetic engineering: Exploring engineered Tregs, gene-modified pancreatic islets, and molecular strategies to modulate antigen presentation and immune recognition.
- Molecular and cellular readouts: Multiparameter flow cytometry, cytokine profiling, qPCR, western blotting, fluorescence microscopy, and functional immune cell assays.
These projects offer opportunities for high-impact research at the intersection of autoimmunity, immunoengineering, and regenerative medicine, with the long-term goal of developing strategies to preserve or restore insulin-producing β cells in T1D.
Trainees will receive interdisciplinary training in immunology, molecular biology, bioengineering, and pancreatic islet biology, with opportunities to present their findings at national conferences, contribute to peer-reviewed publications, and develop expertise in both basic and translational diabetes research.
